Işılay Turan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Işılay Turan has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Cigdem Aydogmus
Department of Pediatric Allergy and Immunology Basaksehir Cam and Sakura City Hospital Istanbul Turkiye
8 shared publications - Selami Ulaş
Department of Pediatric Allergy and Immunology Basaksehir Cam and Sakura City Hospital Istanbul Turkiye
6 shared publications - Sezin Naiboğlu
Department of Pediatric Allergy and Clinical Immunology Başakşehir Çam and Sakura City Hospital İstanbul Türkiye
5 shared publications - Mehmet Halil Celiksoy
Department of Pediatric Allergy and Immunology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, Türkiye
4 shared publications - Ayca Kiykim
Department of Pediatric Allergy and Immunology, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Türkiye
3 shared publications - Betul Gemici Karaaslan
Cerrahpasa Faculty of Medicine, Department of Pediatric Allergy and Immunology Istanbul University‐Cerrahpasa Istanbul Turkiye
3 shared publications
Latest Publications
- 2 November 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (11)
When cure is not enough: Parental anxiety, depression, and caregiver burden after HSCT for inborn errors of immunity
Introduction: Hematopoietic stem cell transplantation (HSCT) is curative for many children with inborn errors of immunity (IEIs). While research has largely focused on survival, immune reconstitution, and transplant‐related complications, the long‐term psychosocial impact on families of medically stable, complication‐free survivors remains poorly understood. Methods: In this cross‐sectional case–control study, 79 children with IEIs who achieved full immune reconstitution after HSCT and were free of chronic disease‐ or transplant‐related complications were compared with 69 age‐ and sex‐matched healthy controls. Parents completed the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and Zarit Burden Interview (ZBI). Caregivers also completed the parent‐report Strengths and Difficulties Questionnaire (SDQ). Linear regression analysis was performed to identify factors associated with caregiver burden. Results: Mothers of transplanted children had significantly higher depression, anxiety, and caregiver burden scores than control mothers (all p ≤ .001). Fathers demonstrated higher depression scores, whereas anxiety scores did not differ significantly. Maternal depression independently predicted caregiver burden ( β = .913, 95% CI 0.512–1.314, p < .001). Children in the patient group showed higher conduct problem and hyperactivity scores, with a trend toward greater internalizing difficulties. Psychological outcomes were not associated with demographic characteristics, disease‐related factors, or time since transplantation. Discussion: Despite successful immune reconstitution and the absence of chronic complications, families continued to experience substantial psychosocial burden. Maternal depressive symptoms emerged as the strongest determinant of caregiver burden. These findings suggest that medical recovery after HSCT does not necessarily translate into psychosocial recovery and support the integration of routine family‐centered psychological assessment into long‐term follow‐up care. image
- 2 November 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (11)
When cure is not enough: Parental anxiety, depression, and caregiver burden after HSCT for inborn errors of immunity
Introduction: Hematopoietic stem cell transplantation (HSCT) is curative for many children with inborn errors of immunity (IEIs). While research has largely focused on survival, immune reconstitution, and transplant‐related complications, the long‐term psychosocial impact on families of medically stable, complication‐free survivors remains poorly understood. Methods: In this cross‐sectional case–control study, 79 children with IEIs who achieved full immune reconstitution after HSCT and were free of chronic disease‐ or transplant‐related complications were compared with 69 age‐ and sex‐matched healthy controls. Parents completed the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and Zarit Burden Interview (ZBI). Caregivers also completed the parent‐report Strengths and Difficulties Questionnaire (SDQ). Linear regression analysis was performed to identify factors associated with caregiver burden. Results: Mothers of transplanted children had significantly higher depression, anxiety, and caregiver burden scores than control mothers (all p ≤ .001). Fathers demonstrated higher depression scores, whereas anxiety scores did not differ significantly. Maternal depression independently predicted caregiver burden ( β = .913, 95% CI 0.512–1.314, p < .001). Children in the patient group showed higher conduct problem and hyperactivity scores, with a trend toward greater internalizing difficulties. Psychological outcomes were not associated with demographic characteristics, disease‐related factors, or time since transplantation. Discussion: Despite successful immune reconstitution and the absence of chronic complications, families continued to experience substantial psychosocial burden. Maternal depressive symptoms emerged as the strongest determinant of caregiver burden. These findings suggest that medical recovery after HSCT does not necessarily translate into psychosocial recovery and support the integration of routine family‐centered psychological assessment into long‐term follow‐up care. image
- Open Access
- 13 June 2026
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 195 (5) , 2923-2930
Beyond immune recovery: Quality of life and psychosocial challenges in children with inborn errors of immunity after transplantation
Introduction: Hematopoietic stem cell transplantation (HSCT) provides definitive treatment for many inborn errors of immunity (IEI). Although most children achieve full immune reconstitution, long-term psychosocial and quality-of-life outcomes in medically stable survivors remain insufficiently understood. Methods: Children aged 8–18 years with IEI who achieved complete immune recovery and had no chronic complications were included. Quality of life and psychological status were evaluated using the Pediatric Quality of Life Inventory (PedsQL-C) and the Revised Children’s Anxiety and Depression Scale (RCADS). Healthy children matched for age, sex, and sociodemographic background served as controls. Results: Thirty-six patients and 41 controls participated. Children post-HSCT had significantly lower physical, psychosocial, and total quality-of-life scores (p = 0.022, 0.015, 0.006) and higher depression scores (p = 0.027). One-quarter of school-aged patients were not attending school, and one-third of families restricted exposure to crowded environments. Conclusion: Despite immune recovery, children remain vulnerable to psychosocial challenges. These findings support incorporation of routine psychological assessment and family counseling into long-term post-HSCT follow‑up.
- 13 June 2026
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 195 (5) , 2923-2930
Open AccessBeyond immune recovery: Quality of life and psychosocial challenges in children with inborn errors of immunity after transplantation
Introduction: Hematopoietic stem cell transplantation (HSCT) provides definitive treatment for many inborn errors of immunity (IEI). Although most children achieve full immune reconstitution, long-term psychosocial and quality-of-life outcomes in medically stable survivors remain insufficiently understood. Methods: Children aged 8–18 years with IEI who achieved complete immune recovery and had no chronic complications were included. Quality of life and psychological status were evaluated using the Pediatric Quality of Life Inventory (PedsQL-C) and the Revised Children’s Anxiety and Depression Scale (RCADS). Healthy children matched for age, sex, and sociodemographic background served as controls. Results: Thirty-six patients and 41 controls participated. Children post-HSCT had significantly lower physical, psychosocial, and total quality-of-life scores (p = 0.022, 0.015, 0.006) and higher depression scores (p = 0.027). One-quarter of school-aged patients were not attending school, and one-third of families restricted exposure to crowded environments. Conclusion: Despite immune recovery, children remain vulnerable to psychosocial challenges. These findings support incorporation of routine psychological assessment and family counseling into long-term post-HSCT follow‑up.
- Open Access
- 1 May 2026
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 54 (3) , 162-171
Depression, anxiety, and quality of life levels in mothers of children with IgE-mediated food allergy and food protein–induced allergic proctocolitis
Background: Childhood food allergies are known to cause various psychosocial disorders in parents and caregivers. The aim of this study is to determine the levels of depression, anxiety, and quality of life in mothers whose children have IgE-mediated food allergy or food protein–induced allergic proctocolitis (FPIAP). Methods: Mothers of children under 5 years of age with IgE-mediated food allergy or FPIAP and healthy children of the same age were administered the Beck’s Depression Inventory (BDI), State-Trait Anxiety Inventory (STAIT-TRAIT), and the Short Form for Quality of Life Measurement-36 (SF-36). Results: A total of 126 mothers were included in the study: Forty-two each in the IgE-mediated group, the FPIAP group, and the healthy control group. Mothers in the IgE-mediated group and FPIAP group had higher depression and STAIT anxiety scores than mothers in the control group (Both p-values are <0.001, and the eta squared values were 0.364 and 0.555, respectively). TRAIT anxiety scores of mothers in the IgE-mediated group were significantly higher than mothers in both the FPIAP group and the control group (Both p-values are <0.001, and the eta squared value was 0.641). Role limitations because of physical health, role limitations because of emotional health, energy/fatigue, emotional well-being, social functioning, and general health scores of mothers in the IgE-mediated group were lower than mothers in the control group (All p-values are <0.001, and the eta squared values were 0.185,0.197, 0.626, 0592, 0.274, and 0.342, respectively). Conclusion: Mothers of children with both IgE-mediated food allergy and FPIAP may experience higher rates of depression and anxiety disorders, as well as decreased quality of life. Mothers of children with IgE-mediated food allergies experience more psychosocial disorders than mothers of children with FPIAP.
- 1 May 2026
- Published by Codon Publications in Allergologia et Immunopathologia
- Vol. 54 (3) , 162-171
Open AccessDepression, anxiety, and quality of life levels in mothers of children with IgE-mediated food allergy and food protein–induced allergic proctocolitis
Background: Childhood food allergies are known to cause various psychosocial disorders in parents and caregivers. The aim of this study is to determine the levels of depression, anxiety, and quality of life in mothers whose children have IgE-mediated food allergy or food protein–induced allergic proctocolitis (FPIAP). Methods: Mothers of children under 5 years of age with IgE-mediated food allergy or FPIAP and healthy children of the same age were administered the Beck’s Depression Inventory (BDI), State-Trait Anxiety Inventory (STAIT-TRAIT), and the Short Form for Quality of Life Measurement-36 (SF-36). Results: A total of 126 mothers were included in the study: Forty-two each in the IgE-mediated group, the FPIAP group, and the healthy control group. Mothers in the IgE-mediated group and FPIAP group had higher depression and STAIT anxiety scores than mothers in the control group (Both p-values are <0.001, and the eta squared values were 0.364 and 0.555, respectively). TRAIT anxiety scores of mothers in the IgE-mediated group were significantly higher than mothers in both the FPIAP group and the control group (Both p-values are <0.001, and the eta squared value was 0.641). Role limitations because of physical health, role limitations because of emotional health, energy/fatigue, emotional well-being, social functioning, and general health scores of mothers in the IgE-mediated group were lower than mothers in the control group (All p-values are <0.001, and the eta squared values were 0.185,0.197, 0.626, 0592, 0.274, and 0.342, respectively). Conclusion: Mothers of children with both IgE-mediated food allergy and FPIAP may experience higher rates of depression and anxiety disorders, as well as decreased quality of life. Mothers of children with IgE-mediated food allergies experience more psychosocial disorders than mothers of children with FPIAP.
- 24 April 2026
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 103 (4) , e70116
Clinical Manifestations and Immunologic Phenotype in Patients With RAG1/2 Mutations: A Single Centre Experience and Description of A Novel Mutation
Recombination‐activating genes (RAG1 and RAG2) encode lymphoid‐specific proteins that are essential for V(D)J recombination during early T‐ and B‐lymphocyte development. Biallelic mutations in these genes result in a broad spectrum of primary immunodeficiency phenotypes, ranging from classical severe combined immunodeficiency (SCID) to combined immunodeficiency, immune dysregulation, autoimmunity, and inflammatory complications. The immunological phenotype varies widely, from T‐B‐NK+ severe combined immunodeficiency (SCID) to combined immunodeficiency (CID), or near‐normal T and B cell counts, and even antibody deficiencies despite preserved pathogen‐specific antibody responses. In this cohort, we aimed to characterize the clinical, immunological, and genetic features, as well as the disease course, of patients diagnosed with RAG1 and RAG2 deficiencies.
- 24 April 2026
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 103 (4) , e70116
Clinical Manifestations and Immunologic Phenotype in Patients With RAG1/2 Mutations: A Single Centre Experience and Description of A Novel Mutation
Recombination‐activating genes (RAG1 and RAG2) encode lymphoid‐specific proteins that are essential for V(D)J recombination during early T‐ and B‐lymphocyte development. Biallelic mutations in these genes result in a broad spectrum of primary immunodeficiency phenotypes, ranging from classical severe combined immunodeficiency (SCID) to combined immunodeficiency, immune dysregulation, autoimmunity, and inflammatory complications. The immunological phenotype varies widely, from T‐B‐NK+ severe combined immunodeficiency (SCID) to combined immunodeficiency (CID), or near‐normal T and B cell counts, and even antibody deficiencies despite preserved pathogen‐specific antibody responses. In this cohort, we aimed to characterize the clinical, immunological, and genetic features, as well as the disease course, of patients diagnosed with RAG1 and RAG2 deficiencies.
- Open Access
- 18 February 2025
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 101 (2) , e70003
Evaluation of T‐cell repertoire by flow cytometric analysis in primary immunodeficiencies with DNA repair defects
The group of patients with DNA‐repair‐defects increases susceptibility to infections due to impaired repertoire diversity. In this context, we aimed to investigate the TCRvβ‐repertoire by flow cytometric analysis and its correlation with clinical entities in a group of IEI patients with DNA repair defects. Peripheral lymphocyte subset and TCRvβ‐repertoire analyses were performed by flow cytometric analysis. The aim was to explore the changing TCR‐Vβ‐repertoire that can predict some clinical entities by investigating the repertoire using flow‐cytometric‐analysis‐based TCR‐Vβ and its interaction with clinical entities in a group of IEI patients with DNA repair defects. TCR‐repertoire of the patients with DNA‐repair‐defects and healthy controls was analysed with flow‐cytometer. The potential of flow‐cytometric analysis of the TCR repertoire as a practical and easily accessible clinical prediction method was investigated. Thirty‐nine‐IEI patients with DNA‐repair‐defects and 15 age‐matched healthy‐controls were included in this study. Peripheral lymphocyte subset and TCR‐Vβ repertoire analyses were performed by flow cytometry. Compared to the control group, 9 out of 24 clones (37.5%) exhibited a statistically significant reduction, while only 3 clones showed a statistically significant increase (p < 0.05). Preferential use of vβ‐genes was associated with some clinical entities. Lower TCR‐vβ‐9 and TCR‐vβ23, higher TCR‐vβ7.2 were found in the patients with pneumonia (n = 13) (p = 0.018, p = 0.044 p = 0.032). AT patients with pneumonia had lower TCR‐vβ‐9 clone than patients without pneumonia (p = 0.008). Skewed proliferation of most TCR‐vβ clones was seen DNA‐repair‐defects, especially AT. In addition, this study showed that preferential use of TCR‐vβ genes could be predictive for some clinical entities.
- 18 February 2025
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 101 (2) , e70003
Open AccessEvaluation of T‐cell repertoire by flow cytometric analysis in primary immunodeficiencies with DNA repair defects
The group of patients with DNA‐repair‐defects increases susceptibility to infections due to impaired repertoire diversity. In this context, we aimed to investigate the TCRvβ‐repertoire by flow cytometric analysis and its correlation with clinical entities in a group of IEI patients with DNA repair defects. Peripheral lymphocyte subset and TCRvβ‐repertoire analyses were performed by flow cytometric analysis. The aim was to explore the changing TCR‐Vβ‐repertoire that can predict some clinical entities by investigating the repertoire using flow‐cytometric‐analysis‐based TCR‐Vβ and its interaction with clinical entities in a group of IEI patients with DNA repair defects. TCR‐repertoire of the patients with DNA‐repair‐defects and healthy controls was analysed with flow‐cytometer. The potential of flow‐cytometric analysis of the TCR repertoire as a practical and easily accessible clinical prediction method was investigated. Thirty‐nine‐IEI patients with DNA‐repair‐defects and 15 age‐matched healthy‐controls were included in this study. Peripheral lymphocyte subset and TCR‐Vβ repertoire analyses were performed by flow cytometry. Compared to the control group, 9 out of 24 clones (37.5%) exhibited a statistically significant reduction, while only 3 clones showed a statistically significant increase (p < 0.05). Preferential use of vβ‐genes was associated with some clinical entities. Lower TCR‐vβ‐9 and TCR‐vβ23, higher TCR‐vβ7.2 were found in the patients with pneumonia (n = 13) (p = 0.018, p = 0.044 p = 0.032). AT patients with pneumonia had lower TCR‐vβ‐9 clone than patients without pneumonia (p = 0.008). Skewed proliferation of most TCR‐vβ clones was seen DNA‐repair‐defects, especially AT. In addition, this study showed that preferential use of TCR‐vβ genes could be predictive for some clinical entities.
- Open Access
- 2 May 2024
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 59 (3) , 325-327
A Rare Clinical Finding in Ataxia Telangiectasia: Granulomatous Skin Lesion
Cite this article as: Naiboğlu S, Ulaş S, Turan I, Erol Çipe F, Çalım Gürbüz B, Aydoğmuş Ç. A rare clinical finding in ataxia telangiectasia: Granulomatous skin lesion. Turk Arch Pediatr. 2024;59(3):325-327.
- 2 May 2024
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 59 (3) , 325-327
Open AccessA Rare Clinical Finding in Ataxia Telangiectasia: Granulomatous Skin Lesion
Cite this article as: Naiboğlu S, Ulaş S, Turan I, Erol Çipe F, Çalım Gürbüz B, Aydoğmuş Ç. A rare clinical finding in ataxia telangiectasia: Granulomatous skin lesion. Turk Arch Pediatr. 2024;59(3):325-327.
- Open Access
- 2 January 2024
- Published by Journal of Molecular Virology and Immunology in Journal of Molecular Virology and Immunology
Hepatic Veno-Occlusive Disease with Immunodeficiency (VODI): A Case Report and Review of Literature
Hepatic veno occlusive disease with immunodeficiency syndrome (VODI) is an autosomal recessive primary immunodeficiency associated with hepatic vascular occlusion and fibrosis. The immunodeficiency is characterized by severe hypogammaglobulinemia, combined T and B cell immunodeficiency, absent lymph node germinal centers, and absence of tissue plasma cells. VODI was first described in 1976 in an Australian Lebanese population. In our patient who came to the emergency department with septic shock, all immunoglobulins were too low to count. In the blood analysis of the patient, it was observed that there was no antibody response. Lymphocyte subgroups were almost normal. According to the whole exome sequence (WES) analysis, it was observed that he had a VODI gene defect. There was an increase in intermittent liver function tests and ursodeoxycholic-acid (UDCA) was started. However, hepatic fibrosis has not yet been detected by radiological methods. During the follow-up of our patient, there was serious weight loss due to chronic (prolonged) norovirus infection. The patient is preparing for a bone marrow transplant. The VODI gene defect should be considered in the differential diagnosis in patients with sepsis, invasive infection, and hypogammaglobulinemia, especially in the early stages of life. With early detection of the disease, patients are monitored regularly with intravenous immunoglobulin (IVIG) prophylactic treatments. In this way, patients can be caught before hepatic fibrosis develops and the development of irreversible damage can be prevented, such as failure of the liver.
- 2 January 2024
- Published by Journal of Molecular Virology and Immunology in Journal of Molecular Virology and Immunology
Open AccessHepatic Veno-Occlusive Disease with Immunodeficiency (VODI): A Case Report and Review of Literature
Hepatic veno occlusive disease with immunodeficiency syndrome (VODI) is an autosomal recessive primary immunodeficiency associated with hepatic vascular occlusion and fibrosis. The immunodeficiency is characterized by severe hypogammaglobulinemia, combined T and B cell immunodeficiency, absent lymph node germinal centers, and absence of tissue plasma cells. VODI was first described in 1976 in an Australian Lebanese population. In our patient who came to the emergency department with septic shock, all immunoglobulins were too low to count. In the blood analysis of the patient, it was observed that there was no antibody response. Lymphocyte subgroups were almost normal. According to the whole exome sequence (WES) analysis, it was observed that he had a VODI gene defect. There was an increase in intermittent liver function tests and ursodeoxycholic-acid (UDCA) was started. However, hepatic fibrosis has not yet been detected by radiological methods. During the follow-up of our patient, there was serious weight loss due to chronic (prolonged) norovirus infection. The patient is preparing for a bone marrow transplant. The VODI gene defect should be considered in the differential diagnosis in patients with sepsis, invasive infection, and hypogammaglobulinemia, especially in the early stages of life. With early detection of the disease, patients are monitored regularly with intravenous immunoglobulin (IVIG) prophylactic treatments. In this way, patients can be caught before hepatic fibrosis develops and the development of irreversible damage can be prevented, such as failure of the liver.
- 14 March 2023
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 8 (1) , 94-98
The Course of COVID-19 in a Patient with Congenital Neutropenia: A Case Report
- 14 March 2023
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 8 (1) , 94-98
The Course of COVID-19 in a Patient with Congenital Neutropenia: A Case Report
- 1 March 2023
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 9 (1) , 63-67
A Case Diagnosed with Chronic Granulomatous Disease Presenting with Dactylitis
- 1 March 2023
- Published by Galenos Yayinevi in Bagcilar Medical Bulletin
- Vol. 9 (1) , 63-67
A Case Diagnosed with Chronic Granulomatous Disease Presenting with Dactylitis